Hepatitis C prevalence among HIV-positive MSM in San Francisco: 2004 and 2008

San Francisco Department of Public Health, San Francisco, CA
Sexually transmitted diseases (Impact Factor: 2.84). 10/2010; 38(3):219-20. DOI: 10.1097/OLQ.0b013e3181f68ed4
Source: PubMed


Recent reports suggest the potential for an epidemic of Hepatitis C among nonintravenous drug-using HIV-positive men who have sex with men. HIV-positive specimens from surveillance surveys in 2004 and 2008 were tested for HCV antibodies. Among noninjection drug using men who have sex with men, HCV prevalence was 8.7% and 4.5% in 2004 and 2008, respectively. There was no evidence of a change in HCV prevalence between 2004 and 2008. Copyright © 2011 American Sexually Transmitted Diseases Association All rights reserved.

3 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: To compare the rates of unprotected anal intercourse (UAI) among men who have sex with men (MSM) in HIV-seropositive sexual relationships with that among men in HIV-seronegative and serodiscordant relationships in the context of an emerging hepatitis C virus (HCV) epidemic among HIV-positive MSM. Time-location sampling was used to obtain a cross-sectional sample of MSM who attended public venues in San Francisco between November 2007 and October 2008 (N = 1199). Behavioural measures of sexual risk-taking at the level of the sexual dyad were administered to the sample. Men in HIV-positive/positive sexual relationships are significantly more likely to have UAI and combine sex and drugs than men in negative/negative sexual relationships. If it is possible to spread HCV infection between HIV-positive men via UAI, very high levels of behavioural risk among positive MSM should exist to facilitate HCV transmission. Identifying the precise behavioural risk factors for HCV among HIV-positive MSM has become an important public health priority.
    Sexually transmitted infections 06/2011; 87(5):439-41. DOI:10.1136/sti.2010.048223 · 3.40 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Serum specimens collected during the 2011 round of National HIV Behavioral Surveillance among men who have sex with men in San Francisco were tested for hepatitis C virus antibodies. Hepatitis C virus infection was found among men who have sex with men with a history of intravenous drug use and those who were already human immunodeficiency virus infected.
    Sexually transmitted diseases 12/2012; 39(12):985-6. DOI:10.1097/OLQ.0b013e3182716e59 · 2.84 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: Sexually transmitted hepatitis C virus (HCV) infection is an emerging epidemic among human immunodeficiency virus (HIV)-infected men who have sex with men (MSM). HCV may be underrecognized in this population, historically thought to be at low risk. Methods: We determined the prevalence and incidence of HCV among HIV-infected men at Fenway Health between 1997 and 2009. We describe characteristics associated with HCV. Results: Of 1171 HIV-infected men, of whom 96% identify as MSM, 1068 (91%) were screened for HCV and 64 (6%) had a positive HCV antibody (Ab) result at initial screening. Among the 995 men whose initial HCV Ab result was negative, 62% received no further HCV Ab testing. Among the 377 men who had ≥1 additional HCV Ab test, 23 (6%) seroconverted over 1408 person-years, for an annualized incidence of 1.63 per 100 person-years (95% confidence interval, .97-2.30). Among the 87 HIV-infected MSM diagnosed with prevalent or incident HCV, 33% reported history of injection drug use, 46% noninjection drug use (NIDU), and 70% sexually transmitted infections (STIs). Sixty-four (74%) of HCV-infected MSM developed chronic HCV; 22 (34%) initiated HCV treatment and 13 (59%) of treated persons achieved a sustained virologic response (SVR). Conclusions: Prevalent and incident HCV, primarily acquired through nonparenteral means, was common in this HIV-infected population despite engagement in care. STIs and NIDU were common among HIV/HCV-coinfected MSM. SVR rates were high among those who underwent HCV treatment. All sexually active and/or substance-using HIV-infected MSM should receive routine and repeated HCV screening to allow for early diagnosis and treatment of HCV.
    Clinical Infectious Diseases 02/2013; 56(10). DOI:10.1093/cid/cit054 · 8.89 Impact Factor
Show more